Oscar Health, Inc. (NYSE:OSCR) Shares Acquired by Scientech Research LLC

Scientech Research LLC raised its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 38.3% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 40,739 shares of the company’s stock after buying an additional 11,287 shares during the period. Scientech Research LLC’s holdings in Oscar Health were worth $644,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Avalon Trust Co bought a new stake in shares of Oscar Health during the 1st quarter worth $69,000. Point72 Hong Kong Ltd purchased a new stake in shares of Oscar Health during the second quarter valued at $78,000. Prevail Innovative Wealth Advisors LLC acquired a new position in shares of Oscar Health in the 4th quarter valued at $92,000. Quest Partners LLC purchased a new position in Oscar Health in the 2nd quarter worth about $93,000. Finally, Amalgamated Bank increased its stake in Oscar Health by 27.7% in the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Stock Performance

Shares of OSCR opened at $20.99 on Friday. The company has a market capitalization of $5.08 billion, a PE ratio of -52.47, a PEG ratio of 43.01 and a beta of 1.61. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91. The company’s 50 day moving average price is $18.48 and its 200 day moving average price is $17.81. Oscar Health, Inc. has a 52 week low of $4.72 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The business had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.13 billion. During the same period in the previous year, the company posted ($0.07) EPS. Oscar Health’s revenue was up 44.6% on a year-over-year basis. Research analysts expect that Oscar Health, Inc. will post 0.01 EPS for the current fiscal year.

Wall Street Analyst Weigh In

OSCR has been the subject of several recent analyst reports. Piper Sandler reiterated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Wells Fargo & Company upped their price target on shares of Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research report on Wednesday, June 12th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $24.17.

Insiders Place Their Bets

In other news, EVP Alessandrea C. Quane sold 16,793 shares of Oscar Health stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $17.06, for a total transaction of $286,488.58. Following the completion of the sale, the executive vice president now directly owns 392,607 shares in the company, valued at approximately $6,697,875.42. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, EVP Alessandrea C. Quane sold 16,793 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the transaction, the executive vice president now owns 392,607 shares in the company, valued at approximately $6,697,875.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Victoria Baltrus sold 4,226 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the completion of the sale, the chief accounting officer now directly owns 140,648 shares of the company’s stock, valued at approximately $2,530,257.52. The disclosure for this sale can be found here. Insiders have sold a total of 169,569 shares of company stock valued at $3,007,069 in the last three months. Insiders own 25.11% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.